Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating diabetes type 2 by administering ultrarapid acting insulin

Method of treating diabetes type 2 by administering ultrarapid acting insulin

US Patent 10857207 · Granted Dec 8, 2020

Estimated economic value: $5,489,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of ultrarapid acting insulin2025
Use of ultrarapid acting insulin2025
Method of treating diabetes type 2 by administering ultrarapid acting insulin2024
Method of treating diabetes type 2 by administering ultrarapid acting insulin2024
Method of treating diabetes type 2 by administering ultrarapid acting insulin2024
Method of treating diabetes type 2 by administering ultrarapid acting insulin2024
Method of treating diabetes type 2 by administering ultrarapid acting insulin2024
Method of treating hypoglycemia events in diabetes treatment2024
Use of ultrarapid acting insulin2024
Use of ultrarapid acting insulin2024
Use of ultrarapid acting insulin2023
Use of ultrarapid acting insulin2023